New Frontiers in RPL Research and Treatment

Asher Bashiri; Avishai Shemesh; Angel Porgador; Gershon Holcberg; Maor Kabessa

doi:10.1007/978-3-319-27452-2_14

New Frontiers in RPL Research and Treatment

Asher Bashiri, Avishai Shemesh, Angel Porgador, Gershon Holcberg, Maor Kabessa

The Shraga Segal Department of Microbiology and Immunology

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

1 Scopus citations

Abstract

In the RPL field, some aspects including evaluation, diagnosis, and treatment have been controversial for many years. Research lacks randomized clinical trials as well as multicenter studies that will help enlarge the number of women inspected in each trial. In order to provide evidence-based recommendations to the couples who deal with RPL, research should take a more creative direction when investigating etiologies and treatments. Here, we focus on the most advanced research in RPL, including multifactorial approach towards RPL, heparin's role not as anticoagulant, immune systems' role, and new discoveries on different molecules. Although some of these articles are only the beginning, exposing the tip of the iceberg, and it might take a long period of time before they achieve their goals.

Original language	English
Title of host publication	Recurrent Pregnancy Loss
Subtitle of host publication	Evidence-Based Evaluation, Diagnosis and Treatment
Publisher	Springer International Publishing
Pages	185-202
Number of pages	18
ISBN (Electronic)	9783319274522
ISBN (Print)	9783319274508
DOIs	https://doi.org/10.1007/978-3-319-27452-2_14
State	Published - 1 Jan 2016

Keywords

Annexin V
Heparin
Immune system
Leptin
Multifactorial etiology
NK cells
Recurrent pregnancy loss

ASJC Scopus subject areas

General Health Professions
General Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/978-3-319-27452-2_14

Cite this

@inbook{eb381bb7aa834ea3a9f3ca5d79ea93b3,

title = "New Frontiers in RPL Research and Treatment",

abstract = "In the RPL field, some aspects including evaluation, diagnosis, and treatment have been controversial for many years. Research lacks randomized clinical trials as well as multicenter studies that will help enlarge the number of women inspected in each trial. In order to provide evidence-based recommendations to the couples who deal with RPL, research should take a more creative direction when investigating etiologies and treatments. Here, we focus on the most advanced research in RPL, including multifactorial approach towards RPL, heparin's role not as anticoagulant, immune systems' role, and new discoveries on different molecules. Although some of these articles are only the beginning, exposing the tip of the iceberg, and it might take a long period of time before they achieve their goals.",

keywords = "Annexin V, Heparin, Immune system, Leptin, Multifactorial etiology, NK cells, Recurrent pregnancy loss",

author = "Asher Bashiri and Avishai Shemesh and Angel Porgador and Gershon Holcberg and Maor Kabessa",

note = "Publisher Copyright: {\textcopyright} Springer International Publishing Switzerland 2016.",

year = "2016",

month = jan,

day = "1",

doi = "10.1007/978-3-319-27452-2_14",

language = "English",

isbn = "9783319274508",

pages = "185--202",

booktitle = "Recurrent Pregnancy Loss",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - New Frontiers in RPL Research and Treatment

AU - Bashiri, Asher

AU - Shemesh, Avishai

AU - Porgador, Angel

AU - Holcberg, Gershon

AU - Kabessa, Maor

N1 - Publisher Copyright: © Springer International Publishing Switzerland 2016.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - In the RPL field, some aspects including evaluation, diagnosis, and treatment have been controversial for many years. Research lacks randomized clinical trials as well as multicenter studies that will help enlarge the number of women inspected in each trial. In order to provide evidence-based recommendations to the couples who deal with RPL, research should take a more creative direction when investigating etiologies and treatments. Here, we focus on the most advanced research in RPL, including multifactorial approach towards RPL, heparin's role not as anticoagulant, immune systems' role, and new discoveries on different molecules. Although some of these articles are only the beginning, exposing the tip of the iceberg, and it might take a long period of time before they achieve their goals.

AB - In the RPL field, some aspects including evaluation, diagnosis, and treatment have been controversial for many years. Research lacks randomized clinical trials as well as multicenter studies that will help enlarge the number of women inspected in each trial. In order to provide evidence-based recommendations to the couples who deal with RPL, research should take a more creative direction when investigating etiologies and treatments. Here, we focus on the most advanced research in RPL, including multifactorial approach towards RPL, heparin's role not as anticoagulant, immune systems' role, and new discoveries on different molecules. Although some of these articles are only the beginning, exposing the tip of the iceberg, and it might take a long period of time before they achieve their goals.

KW - Annexin V

KW - Heparin

KW - Immune system

KW - Leptin

KW - Multifactorial etiology

KW - NK cells

KW - Recurrent pregnancy loss

UR - http://www.scopus.com/inward/record.url?scp=84958916772&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-27452-2_14

DO - 10.1007/978-3-319-27452-2_14

M3 - Chapter

AN - SCOPUS:84958916772

SN - 9783319274508

SP - 185

EP - 202

BT - Recurrent Pregnancy Loss

PB - Springer International Publishing

ER -

New Frontiers in RPL Research and Treatment

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this